Prudential Financial’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,995
| Closed | -$15.2K | – | 2513 |
|
|
2025
Q1 | $15.2K | Buy |
10,995
+580
| +6% | +$800 | ﹤0.01% | 2268 |
|
|
2024
Q4 | $31.7K | Buy |
+10,415
| New | +$31.7K | ﹤0.01% | 2253 |
|
|
2023
Q1 | – | Sell |
-12,800
| Closed | -$20.9K | – | 2673 |
|
|
2022
Q4 | $20.9K | Buy |
12,800
+1,800
| +16% | +$2.93K | ﹤0.01% | 2565 |
|
|
2022
Q3 | $34K | Buy |
+11,000
| New | +$34K | ﹤0.01% | 2592 |
|